Printer Friendly

WISCONSIN PHARMACAL COMPANY, INC; FEMALE CONDOM APPLICATION SUBMITTED TO FDA

                   WISCONSIN PHARMACAL COMPANY, INC;
              FEMALE CONDOM APPLICATION SUBMITTED TO FDA
    JACKSON, Wis., Nov. 4 -- John A. Wundrock, R.Ph., president and CEO of Wisconsin Pharmacal Company, Inc. (NASDAQ: WPCI), announced that the Pre-Market Approval (PMA) Application for the Reality vaginal pouch (female condom) was submitted to the Food and Drug Administration on Oct. 29, 1991.
    Reality is a patented barrier device (female condom) designed to help prevent sexually transmitted disease, including AIDS, and unwanted pregnancy.  Unlike male condoms, its use is controlled by the female. Reality has been under development for about four years.
    Studies have shown that the AIDS virus and viral particles smaller than the Hepatitis B virus (the smallest virus known to cause a sexually transmitted disease) cannot penetrate the Reality sheath.  Clinical trials have included approximately 1,700 women and 30,000 uses in 71 medical centers in 10 countries.
    Wisconsin Pharmacal develops and markets innovative health care, leisure time and household products.
    -0-           11/4/91
    /CONTACT:  John A. Wundrock, president and CEO of Wisconsin Pharmacal, 414-677-4121/
    (WPCI) CO:  Wisconsin Pharmacal Company Inc. ST:  Wisconsin IN:  MTC SU:  PDT SM -- NY039 -- 0685 11/04/91 11:19 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 4, 1991
Words:193
Previous Article:GRC INTERNATIONAL REPORTS EARNINGS FOR THE FIRST QUARTER ENDED SEPT. 30, 1991
Next Article:DOT PRESENTS SAFETY AWARDS FOR ENGINEERING EXCELLENCE
Topics:


Related Articles
WISCONSIN PHARMACAL COMPANY FEMALE CONDOM APPLICATION SCHEDULED FOR ADVISORY PANEL REVIEW
WISCONSIN PHARMACAL COMPANY ANNOUNCES SUBMISSION OF DATA TO THE FDA ON FEMALE CONDOM
WISCONSIN PHARMACAL COMPANY ANNOUNCES SUBMISSION OF DATA TO THE FDA ON FEMALE CONDOM
REALITY FEMALE CONDOM DEVELOPER RECEIVES ENTREPRENEUR AWARD
FEMALE CONDOM IS LAUNCHED IN UNITED KINGDOM
REALITY FEMALE CONDOM SCHEDULED FOR FDA ADVISORY PANEL REVIEW
WISCONSIN PHARMACAL RECEIVES FDA 'APPROVABLE LETTER' FOR REALITY, THE FIRST FEMALE CONDOM
FEMALE CONDOM MARKETER DISPUTES MISLEADING ARTICLE IN INVESTORS BUSINESS DAILY
WISCONSIN PHARMACAL COMPANY, INC. REPORTS THIRD QUARTER OPERATING RESULTS
WISCONSIN PHARMACAL COMPANY, INC. REPORTS THIRD QUARTER OPERATING RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters